CSEM Stream

CSEMS5 - Craniopharyngioma: Novel Approaches to Treatment

Friday, November 28, 2025

08:00 - 09:00 Toronto

Location: Room 205

Speaker(s)

Kirstie Lithgow, MD FRCPC (she/her/hers)

Clinical Associate Professor
University of Calgary
Cumming School of Medicine
Calgary, Alberta, Canada

Disclosure(s): Recordati Rare Diseases: Advisory Board (Ongoing)
MC

Michael Cusimano, MD, FRCSC, DABNS, FACS, PhD, MHPE

University of Toronto, Canada

Disclosure information not submitted.

Moderator(s)

SV

Stan Van Uum, MD, PhD (he/him/his)

Endocrinology & Metabolism Specialist
Western University
Western University
London, Ontario, Canada

Disclosure(s): Ipsen Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medunik: Advisory Board (Ongoing); Novo-Nordisk: Advisory Board (Terminated, November 23, 2025); Pfizer Canada: Advisory Board (Ongoing); Recordati Rare Disease: Advisory Board (Ongoing)

Disclosure(s):

Kirstie Lithgow, MD FRCPC: Recordati Rare Diseases: Advisory Board (Ongoing)

Stan Van Uum, MD, PhD: Ipsen Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medunik: Advisory Board (Ongoing); Novo-Nordisk: Advisory Board (Terminated, November 23, 2025); Pfizer Canada: Advisory Board (Ongoing); Recordati Rare Disease: Advisory Board (Ongoing)

Describe the epidemiology and presentation of craniopharyngioma.
Review the pathology and genetics of craniopharyngioma.
Contrast papillary versus adamantinomatous subtypes.
Review the role of surgery, radiation and BRAF targeted treatment modalities

Learning Objectives:

Describe the epidemiology and presentation of craniopharyngioma;
Review the pathology and genetics of craniopharyngioma;
Contrast papillary versus adamantinomatous subtypes;
Review the role of surgery, radiation and BRAF targeted treatment modalities.